SLU-PP-332

SLU-PP-332 is a highly experimental exercise-mimetic research compound studied for ERR-driven mitochondrial and metabolic signaling, with the source adapting murine-style logic into a twice-daily peptide-page format.

Profile · 01

Overview

SLU-PP-332 is an experimental small-molecule-style metabolic research compound often discussed alongside exercise-mimetic concepts, mitochondrial biogenesis, and ERR-related signaling. The source includes it in the peptide library because of overlapping audience interest, even though it is more of a research metabolic agent than a classic peptide.

This page is another edge case for the library because the source presents a twice-daily injection schedule and explicitly notes that murine work used intraperitoneal dosing. Human protocol certainty is extremely limited.

At a Glance

Goal
Support experimental metabolic, mitochondrial, and exercise-mimetic research
Categories
Exercise MimeticMetabolic SupportMitochondrial FunctionPreclinical Research
Synergistic
GW501516 · SR9009 · AICAR
Profile · 02

Protocol

Suggested twice-daily research extrapolation based on preclinical dosing logic.

Reconstitute
Add 3.0 mL bacteriostatic water to a 5 mg vial for about 1.67 mg/mL concentration
Typical daily range
1250-2500 mcg total per day, split into two injections
Start
625 mcg twice daily for Weeks 1-2
Target
1250 mcg twice daily by Weeks 3-8
Frequency
Twice daily (subcutaneous), though the source notes murine studies used intraperitoneal dosing
Cycle Length
8-12 weeks; no human cycling data available
Timing
Morning and evening with systematic site rotation
Route
Subcutaneous
Cycle
8-12 weeks in a research context

Inject twice daily in a research-only context. This is one of the least clinically grounded entries in the library, so the key value of the page is organizing the source logic rather than implying human-established best practice.

Dose progression

Weeks 1-2
1250 mcg total (625 mcg x2) · 37.5 units (0.375 mL) x2
Weeks 3-8
2500 mcg total (1250 mcg x2) · 75 units (0.75 mL) x2

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How SLU-PP-332 works.

The source presents SLU-PP-332 as an exercise-mimetic metabolic research compound tied to mitochondrial and endurance-related signaling, likely through ERR pathway activation discussions.

Human dosing certainty is weak. The page is best understood as a structured summary of preclinical extrapolation, not as a mature clinical protocol.

Science · 02

Effects

Observations from clinical or preclinical literature.

May support experimental mitochondrial and metabolic-signaling goals
Often discussed for exercise-mimetic and endurance-oriented research
Twice-daily structure reflects the source rather than a broadly validated human standard
Human safety and efficacy data are very limited
Injection-site irritation may occur
Science · 03

Caution

Not recommended during pregnancy or breastfeeding because safety data is absent
Use caution with cardiovascular, metabolic, or hepatic conditions
This is a preclinical-style entry and should be treated as such

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Protein intake
Supports muscle and recovery goals when metabolic output rises.
Electrolytes
Useful if training volume or metabolic stress increases.
Sleep
Critical because recovery capacity still limits adaptation.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Pair with sensible training, not with reckless overreaching
Maintain hydration, protein intake, and recovery support
Track energy and recovery because more metabolic drive is not automatically better
Keep expectations firmly in the research category
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Training capacity and endurance - useful for functional context tracking
  2. Recovery and fatigue - helps distinguish adaptation from overload
  3. Body composition - useful when metabolic goals are central
  4. Injection-site reactions - note redness, swelling, or discomfort
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during experimental use.
CBC (Complete Blood Count)
General baseline and follow-up monitoring.
Fasting glucose and lipid panel
Useful metabolic context markers.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 5 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites carefully because the protocol uses two injections per day
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile syringe for each injection and dispose of it safely
This page summarizes a highly experimental, preclinical-style protocol
Twice-daily dosing increases the need for organized site rotation and adherence tracking
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. SLU-PP-332 preclinical literature
    Background research on metabolic and mitochondrial-signaling effects.
    https://pubmed.ncbi.nlm.nih.gov/
  2. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
On this page